Objective To review the epidemiology of gout and associated comorbidities. Methods We
review the key published studies of the epidemiology of gout and associated comorbidities …

Background New drugs and new evidence concerning the use of established treatments
have become available since the publication of the first European League Against …

Importance Gout is associated with cardiovascular diseases. The temporal association
between gout flares and cardiovascular events has not been investigated. Objective To …

Objective To provide guidance for the management of gout, including indications for and
optimal use of urate‐lowering therapy (ULT), treatment of gout flares, and lifestyle and other …

Objective To estimate the current prevalence rates and decadal trends of gout and
hyperuricemia in the US, as well as the prevalence of urate‐lowering therapy (ULT) among …

Although gout is the most common inflammatory arthritis, it is still frequently misdiagnosed.
New data on imaging and clinical diagnosis have become available since the first EULAR …

Gout is a crystal-deposition disease that results from chronic elevation of uric acid levels
above the saturation point for monosodium urate (MSU) crystal formation. Initial presentation …

Objective To describe the levels and trends of point prevalence, annual incidence, and
years lived with disability (YLD) for gout and its attributable risk factors in 195 countries and …

Gout is the most common cause of inflammatory arthritis worldwide. In UK general practice,
the overall prevalence has increased from 1.4% in 1999 to 2.49% in 2012 [1], despite the …

Elevated serum urate levels cause gout and correlate with cardiometabolic diseases via
poorly understood mechanisms. We performed a trans-ancestry genome-wide association …